Eosinophils and Interleukin-5

This publication has 13 references indexed in Scilit:

• Effect of SCH55700, a Humanized Anti-Human Interleukin-5 Antibody, in Severe Persistent Asthma
  American Journal of Respiratory and Critical Care Medicine, 2003
• Omalizumab improves asthma-related quality of life in patients with severe allergic asthma
  Journal of Allergy and Clinical Immunology, 2003
• Eosinophil's Role Remains Uncertain as Anti–Interleukin-5 only Partially Depletes Numbers in Asthmatic Airway
  American Journal of Respiratory and Critical Care Medicine, 2003
• Decreased Expression of Membrane IL-5 Receptor α on Human Eosinophils: I. Loss of Membrane IL-5 Receptor α on Airway Eosinophils and Increased Soluble IL-5 Receptor α in the Airway After Allergen Challenge
  The Journal of Immunology, 2002
• Interleukin-5 and eosinophils as therapeutic targets for asthma
  Trends in Molecular Medicine, 2002
• The IL-5 receptor on human bronchus selectively primes for hyperresponsiveness
  Journal of Allergy and Clinical Immunology, 2002
• Elemental signals regulating eosinophil accumulation in the lung
  Immunological Reviews, 2001
• Targeting cytokines in asthma therapy: round one
  The Lancet, 2000
• Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors.
  The Journal of Experimental Medicine, 1988
• IDENTIFICATION BY IMMUNOFLUORESCENCE OF EOSINOPHIL GRANULE MAJOR BASIC PROTEIN IN LUNG TISSUES OF PATIENTS WITH BRONCHIAL ASTHMA
  The Lancet, 1982